Our annual 4-day conference held in the summer, called the DEF Essential Resource Meeting (also known as DERM), is the Clinically Relevant and Practical Case-Based Dermatology NP and PA CME Education Experience™
Bonus Medical Dermatology CME Videos
The live program has concluded.
If you attended, please click on the "Take Post-Test" button to claim your credit. If you did not attend, please stay tuned for the archived version, which will be available soon for on-demand viewing.
Details
Learning Objectives
Upon completion of this activity, the participant should be able to:
- Through case-based presentation and discussion panels, summarize updates in diagnosis, classification, therapies, and immune-system targets in psoriasis, PsA, and AD and describe their clinical implications.
- Cite the mechanisms of action of various drugs that are commonly prescribed by dermatologists and devices that are used by dermatology medical health professionals to treat skin conditions.
Accreditation
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Evolve Medical Education, LLC, and the Dermatology Education Foundation, Physician Resources, LLC. Evolve Medical Education, LLC is accredited by the ACCME to provide continuing medical education for physicians.
Designation Statement
Evolve Medical Education, LLC designates this enduring material for a maximum of 10.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
PHYSICIAN ASSISTANT CONTINUING EDUCATION
PAs may claim a maximum of 10.75 Category 1 credits for completing this activity. National Commission on Certification of Physician Assistants (NCCPA) accepts AMA PRA Category 1 Credits™ from organizations accredited by ACCME or a recognized state medical society.
NURSE PRACTITIONER CONTINUING EDUCATION
The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credits™ from organizations accredited by the ACCME. Individuals are responsible for checking with the AANPCP for further guidelines.
This activity is designated for 1.75 pharmacology credits.
Faculty and Disclosures
DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.The following faculty/staff members have the following financial relationships with ineligible companies.
April Armstrong, MD, MPH, FAAD, has had a financial agreement or affiliation during the past year with the following Ineligible companies in the form of Consultant: AbbVie, Almirall, Arcutus, ASLAN, Beiersdorf, Boehringer Ingelheim, BMS, Dermavant, Dermira, EPI Health, Janssen, Incyte, Leo, Lilly, Modmed, Nimbus, Novartis, Ortho Dermatologics, Parexel, Pfizer, Sun, Sanofi, Regeneron Pharmaceuticals, and UCB.
Hilary Baldwin, MD, FAAD, has had a financial agreement or affiliation during the past year with the following ineligible companies in the form of Consultant/Speaker’s List: Almirall, Bausch Health, Galderma, and Sun Pharma. Consultant: Journey. Speaker’s List: Novan.
Davie Cohen, MD, MPH, FAAD, has had a financial agreement or affiliation during the past year with the following ineligible companies in the form of Consultant: Asana, Cosmetic Ingredient Review (CIR), Dermavant, Ferndale Laboratories, Novartis, SFJ, FIDE, and UCB. Stock/Shareholder and Board of Directors: Evommune, and Timber.
Adam Friedman, MD, FAAD, has had a financial agreement or affiliation during the past year with the following ineligible companies in the form of Consultant: AbbVie, Aveeno, Boehringer Ingelheim, BMS, Galderma, Incyte, Janssen, La Roche Posay, Mino Labs, Novartis, Pfizer, Regeneron Pharmaceuticals, and Sanofi. Grant/Research Support: Galderma, and Pfizer. Speaker’s List: AbbVie, BMS, Incyte, Janssen, Regeneron Pharmaceuticals, Sanofi. Share/Stockholder: Microcures, and Zylo Therapeutics.
Brad Glick, DO, MPH, FAAD, has had a financial agreement or affiliation during the past year with the following ineligible companies in the form of Advisor: Abbvie, Amgen, BMS, Dermavant Sciences, Dermira, Epi Health, Galderma, Incyte, Leo Pharma, Lilly, Novartis, Ortho Dermatologics, Pfizer, Sanofi/Genzyme, Sun Pharma, and UCB. Grant/Research Support: AbbVie, Amgen, AstraZeneca, Brickell Biotech, BMS, Cara Therapeutics, ChemoCentryx, CorEvitas Registry PSO, CorEvital Registry AD, Dermira, Dermavant Sciences, Galderma, Lilly, Nimbus Lakshmi, Inc., PROSE Registry for AD, and Sun Pharma. Speaker’s List: AbbVie, Amgen, BMS, Dermavant Sciences, Dermira, Galderma, Incyte, Janssen, Lilly, Novartis, Ortho Dermatologics ,Pfizer, Regeneron Pharmaceuticals, Sanofi/Genzyme, Sun Pharma, and UCB. Stock/Shareholder: Top MD
Julie C. Harper, MD, FAAD, has had a financial agreement or affiliation during the past year with the following ineligible companies in the form of Consultant: Almirall, BioPharmX, Cassiopeia, Cutanea, Cutera, Dermira, EPI, Galderma, LaRoche-Posay, Sun Pharma, and Vyne. Speaker’s List: Almirall, EPI, Galderma, Ortho, and Vyne.
Theodore Rosen, MD, FAAD, has had a financial agreement or affiliation during the past year with the following ineligible companies in the form of Consultant: Almirall, DermTech, and Verrica Pharmaceuticals.
Linda Stein Gold, MD, FAAO, has had a financial agreement or affiliation during the past year with the following ineligible companies in the form of Consultant: AbbVie, Almirall, Amgen, Arcutis, BMS, Cutera, Dermavant, Incyte, Lilly, Janssen, Galderma, Pfizer, Regeneron/Sanofi, and UCB. Grant/Research Support: AbbVie, Amgen, Arcutis, Dermavant, Galderma, Incyte, Lilly, and Pfizer. Speaker’s List: AbbVie, Almirall, Amgen, BMS, Galderma, Incyte, Pfizer, Regeneron/Sanofi, Sun Pharma, and UCB.
The staff and planners of Evolve Medical Education, Dermatology Education Foundation and Physician Education Resources have no financial agreements with ineligible companies.
System Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
- Apple Safari for Mac OS and iOS
- Mozilla Firefox for Windows, Mac OS, iOS, and Android
- Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+
Publication Dates
Expiration Date:
10.75 credits
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!